D. E. Shaw & Co., Inc. - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$52,000
-25.7%
13,9330.0%0.00%
Q1 2016$70,000
-66.3%
13,933
-46.8%
0.00%
Q4 2015$208,000
-18.8%
26,200
-17.3%
0.00%
Q3 2015$256,00031,6660.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,857,667$4,572,0005.05%
Clarus Ventures, LLC 2,752,488$4,404,0003.28%
SPHERA FUNDS MANAGEMENT LTD. 388,030$621,0000.12%
Rhenman & Partners Asset Management AB 310,756$497,0000.08%
BOSTON FAMILY OFFICE LLC 24,467$39,0000.01%
OPPENHEIMER & CO INC 90,000$144,0000.00%
Alyeska Investment Group, L.P. 221,281$354,0000.00%
A.R.T. Advisors, LLC 46,747$74,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 101,347$162,0000.00%
Acrospire Investment Management LLC 680$1,0000.00%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders